Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of WPQW Granule for Overlap of Non-Erosive Reflux Disease(NERD) and Diarrhea Predominant Diarrhea Irritable Bowel Syndrome(IBS-D)
NCT05369884 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of WPQW Granule for Overlap of Non-Erosive Reflux Disease(NERD) and Diarrhea Predominant Diarrhea Irritable Bowel Syndrome(IBS-D)
- Lead sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 1, 2021
- Completion date
- May 31, 2023
- Enrollment
- 216 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea-predominant irritable bowel syndrome, non-erosive reflux disease